Beijing Huilongguan Hospital
🇨🇳China
Clinical Trials
17
Active:0
Completed:11
Trial Phases
3 Phases
Phase 1:1
Phase 3:2
Not Applicable:14
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials
Not Applicable
14 (82.4%)Phase 3
2 (11.8%)Phase 1
1 (5.9%)The Therapeutic Mechanism of Compassion-Based Family Intervention
Not Applicable
Not yet recruiting
- Conditions
- Emotional Disorder
- First Posted Date
- 2025-08-22
- Last Posted Date
- 2025-08-22
- Lead Sponsor
- Beijing HuiLongGuan Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT07138417
- Locations
- 🇨🇳
Anhui Mental Health Center, Hefei, Anhui, China
🇨🇳Institute of Psychology, Chinese Academy of Sciences, Beijing, Beijing, China
tACS Treatment for Cognitive Impairments in Methamphetamine Addicts
Not Applicable
Recruiting
- Conditions
- Methamphetamine Abuse
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2024-03-04
- Lead Sponsor
- Beijing HuiLongGuan Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT06292156
- Locations
- 🇨🇳
Xin Hua Drug Rehabilitation Center, Mianyang, China
Study on the Efficacy Mechanism of Natural Psychotherapy for Neurosis
Not Applicable
Recruiting
- Conditions
- Obsessive-Compulsive Disorder
- First Posted Date
- 2022-09-23
- Last Posted Date
- 2024-12-30
- Lead Sponsor
- Beijing HuiLongGuan Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT05552014
- Locations
- 🇨🇳
Anhui Mental Health Center, Hefei, Anhui, China
🇨🇳Institute of Psychology, Chinese Academy of Sciences, Beijing, China
Ginkgo Biloba Extract in the Treatment of Schizophrenia
Not Applicable
Completed
- Conditions
- Schizophrenia
- Interventions
- Drug: Placebo oral tablet
- First Posted Date
- 2022-02-28
- Last Posted Date
- 2022-02-28
- Lead Sponsor
- Beijing HuiLongGuan Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05258123
- Locations
- 🇨🇳
Beijing HuiLongGuan Hospital, Beijing, China
The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia
Not Applicable
Completed
- Conditions
- Schizophrenia
- Interventions
- Drug: risperidone-sertraline combinationDrug: ziprasidone-sertraline combinationDrug: olanzapine-sertraline combinationDrug: paliperidone-sertraline combination
- First Posted Date
- 2019-09-03
- Last Posted Date
- 2019-09-03
- Lead Sponsor
- Beijing HuiLongGuan Hospital
- Target Recruit Count
- 1640
- Registration Number
- NCT04076371
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found